[Event Report] The 52nd Breakfast Meeting: Healthcare Sustainability
date : 4/30/2015
Speaker Hiroi Yoshinori, Professor, Faculty of Law, Politics and Economics, Chiba University
Date April 22, 2015 8:00-9:15
Venue Andersen (Aoyama)
On April 22, 2015, Health and Global Policy Institute (HGPI) held a Breakfast Meeting and welcomed as guest speaker Professor Hiroi Yoshinori, professor of health policy Chiba University and HGPI board member, to discuss healthcare sustainability in Japan, a topic of growing importance.
Discussion Overview
Introduction
While healthcare sustainability is extremely important, there has yet to be much discussion on this topic. Healthcare involves a variety of important topics and, when addressing these topics, a wide range of viewpoints and perspectives emerge. That HGPI has chosen to bring this topic to the table for discussion is extremely meaningful.
Perspectives on Sustainable Healthcare
Two opposing viewpoints exist regarding the scale of healthcare expenditures. The first looks at healthcare as the largest growth industry and views increasing healthcare expenses as a means to promote employment and global competitiveness. The second considers healthcare expenses, unlike expenses of other sectors, to be undesired expenses that should be kept at a minimum. Each of these viewpoints offers important points. What becomes critical to this debate is the lens of healthcare sustainability. The scale of healthcare expenditures is not a simple debate on small versus large. Instead, how resources are used within the entire healthcare system is of critical importance.
Issues Regarding Healthcare Sustainability
Healthcare sustainability encompasses a variety of issues, including the scale of expenditures, the allocation of financial resources, costs associated with technology and innovation, ageing communities, and environmental health issues.
1. The allocation of financial resources: Which healthcare fields should receive priority when allocation financial resources?
Financial resources for healthcare are allocated at two levels: the core level and the peripheral level. In the future, more resources should be allocated to activities at the peripheral level, such as R&D, prevention and health promotion, nursing care and social welfare. In response, we will see decreased burden on core healthcare services, such as diagnosis and treatment, enabling us to increase the cost-effectiveness of the entire healthcare system.
However, at the same time, cost-sharing between the public and private sectors is another issue. The majors sectors related to diagnosis and treatment should, with a focus on neutrality and efficiency, provide the public with the proper level of assurance. In this context, there is a risk of market failures and it is necessary to take actions to avoid these.
And, it must be noted that statistical analysis using national healthcare expenditures fails to include costs related to services not covered by insurance. This is a major discrepancy and requires that international comparisons be handled very carefully.
2. The allocation of financial resources: Distribution of hospitals and clinics
Earnings differ between hospitals and clinics, and even amongst hospitals there are differences among hospitals. This variation does not correlate with evaluation of fees. To better understand this, it is helpful to understand the structure from which the current system has emerged. The current healthcare service system is based on a framework established in 1958 when healthcare services were mainly providers by practitioners in clinics and care was provided based on an acute disease model.
Given this, the Japanese medical fee system faces four structural challenges:
・Weak evaluation of hospitals and divided hospitalizations
・Weak evaluation of high-level medical care
・Weak approach to the evaluation of team-based healthcare, including social and mental health support for patients
・Weak approach to the evaluation of healthcare quality
Moving forward, it will be important to adequately evaluate high-level hospitals and the expansions of medical fees that follow. It will also be necessary to actively address the needs of those who receive healthcare. And given that healthcare expenses cannot be expanded limitlessly, there may need the need to impose general regulations.
Healthcare Innovation and Healthcare Expenses
The question of whether innovation increases or decreases healthcare expenses has two different answers. The first response is referred to as the Inverted U-shaped Curve Hypothesis. This hypothesis basically states that expenses for basics healthcare services (non-technology based services) are low, while expenses for developing technologies rise increasingly throughout the development stage. When the innovation reaches a level referred to as “pure technology,” the expense curve reverts down.
The second response is called the Effect Recession Theory. This theory states that innovations for early stage healthcare issues, such as vaccines for infectious diseases, are highly cost-effective. On the other hand, innovative technologies for long-term healthcare issues, such as chronic diseases do not enjoy the same levels of cost-effectiveness.
The differences of the two opinions are the differences between seeds implanted in emerging technology from the provider standpoint and the needs from the patient standpoint. The provider perspective of “seeds” prioritizes the high potential of breakthroughs in life science. In contrast, the patient perspective of “needs” prioritizes the need to address existing diseases, which could decline if too much focus is placed on innovation, making this as debate with deep roots in social and cultural patterns. Given this, the transition from a conventional healthcare model to a biomedical framework will be a challenge.
Recently, social epidemiology and social determinants of heath (SDH) have been popular discussion topics worldwide. Therefore, it is crucial for us to consider such inclusive models based on sustainability.
(The above is based on a quote from Prof. Yoshinori Hiroi’s book 「持続可能な福祉社会」(2006) (Shizoku Kanouna Fukushi Shakai, 2006) (written in Japanese).
Ageing and Communities, Cities, and Regions
According to a national survey in 2010, Nagano Prefecture has the highest average life expectancy in Japan. And per capita costs for late-stage healthcare for older persons in Nagano is the fourth lowest in Japan. Nagano’s success has come to be known as the Nagano Model, which encompasses factors such as a high employment rate of older persons, persons enjoying a sense of life purpose, the highest vegetable intake in the nation, a health promotion program guided by volunteer health workers, and prevention activities led by healthcare professionals. This model can be applied in other areas or can be applied more broadly.
In Japan, where the number of older persons who live alone is increasing, social capital and community can be used to address various issues. One such issue is that many older persons who live alone find themselves without a place to go and where they feel comfortable. From this point of view, Japan can learn from European models and incorporate social welfare and healthcare policy into urban planning and community policy.
The Environment and Healthcare
The concept of sustainability first gained attention in a report by the United Nations World Commission on Environment and Development (WCED) published in 1987 called, “Our Common Future.”
With limited resources, the way in which we achieve development that addresses the needs of the current generation without impairing our ability to meet the needs of future generations can be applied to healthcare. It is important to consider perspectives from evolutionary medicine that state that the fundamental causes of disease lay in society and one’s surrounding environment.
The crossroads of the environment and healthcare is of great significance. This means that we take a holistic approach that incorporates the various elements that exist in society. I look forward to HGPI’s furthering the discussion on healthcare sustainability.
Registration deadline: 2015-04-20
Exhibition date:2015-04-22
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)